Safar Bashar, Jobanputra Sanjay, Sands Dana, Weiss Eric G, Nogueras Juan J, Wexner Steven D
Department of Colorectal Surgery, Cleveland Clinic Florida, Weston, Florida, USA.
Dis Colon Rectum. 2009 Feb;52(2):248-52. doi: 10.1007/DCR.0b013e31819c96ac.
This study was designed to analyze the efficacy of the Cook Surgisis AFP anal fistula plug for the management of complex anal fistulas.
This was a retrospective review of all patients prospectively entered into a database at our institution who underwent treatment for complex anal fistulas using Cook Surgisis AFP anal fistula plug between July 2005 and July 2006. Patient's demographics, fistula etiology, and success rates were recorded. The plug was placed in accordance with the inventor's guidelines. Success was defined as closure of all external openings, absence of drainage without further intervention, and absence of abscess formation.
Thirty-five patients underwent 39 plug insertions (22 men; mean age, 46 (range, 15-79) years). Three patients were lost to follow-up, therefore, 36 procedures to be analyzed. The fistula etiology was cryptoglandular in 31 (88.6 percent) patients and Crohn's disease associated in the other 4 (11.4 percent). There were 11 smokers and 3 patients with diabetes. The mean follow-up was 126 days (standard = 69.4). The overall success rate was 5 of 36 (13.9 percent). One of the four Crohn's disease-associated fistulas healed (25 percent) and 4 of 32 (12.5 percent) procedures resulted in healing of cryptoglandular fistulas. In 17 patients, further procedures were necessary as a result of failure of treatment with the plug. The reasons for failure were infection requiring drainage and seton placement in 8 patients (25.8 percent), plug dislodgement in 3 (9.7 percent), persistent drainage/tract and need for other procedures in 20 patients (64.5 percent).
The success rate for Surgisis AFP anal fistula plug for the treatment of complex anal fistulas was (13.9 percent), which is much lower than previously described. Further analysis is needed to explain significant differences in outcomes.
本研究旨在分析库克外科手术公司生产的AFP肛瘘栓治疗复杂性肛瘘的疗效。
对2005年7月至2006年7月期间在本机构前瞻性录入数据库的所有使用库克外科手术公司AFP肛瘘栓治疗复杂性肛瘘的患者进行回顾性研究。记录患者的人口统计学资料、肛瘘病因及成功率。按照发明者的指导原则放置栓塞。成功定义为所有外口闭合、无需进一步干预即无引流且无脓肿形成。
35例患者接受了39次栓塞植入(22例男性;平均年龄46岁(范围15 - 79岁))。3例患者失访,因此,有36例手术可供分析。肛瘘病因在31例(88.6%)患者中为隐窝腺源性,另外4例(11.4%)与克罗恩病相关。有11例吸烟者和3例糖尿病患者。平均随访时间为126天(标准差 = 69.4)。总体成功率为36例中的5例(13.9%)。4例与克罗恩病相关的肛瘘中有1例愈合(25%),32例手术中有4例(12.5%)使隐窝腺源性肛瘘愈合。17例患者因栓塞治疗失败需要进一步手术。失败原因包括8例(25.8%)因感染需要引流和放置挂线,3例(9.7%)栓塞移位,20例(64.5%)持续引流/瘘管存在且需要其他手术。
库克外科手术公司AFP肛瘘栓治疗复杂性肛瘘的成功率为13.9%,远低于先前报道。需要进一步分析以解释结果中的显著差异。